Felicitas Schulz
Overview
Explore the profile of Felicitas Schulz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jager P, Biermann B, Liebers N, Schulz F, Baermann B, Twarock S, et al.
EJHaem
. 2025 Mar;
6(2):e70012.
PMID: 40041662
Background: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a key treatment for hematologic malignancies, but donor selection impacts outcomes. Results: In a cohort of 152 patients undergoing allo-SCT from 2012...
2.
Schulz F, Roggenbuck C, Kundgen A, Kasprzak A, Nachtkamp K, Jager P, et al.
Ann Hematol
. 2025 Jan;
104(1):231-239.
PMID: 39794531
As median age of patients with acute myeloid leukemia is 72 years, older patients continue to be a vulnerable cohort representing significant challenges in clinical practice. Patient-specific comorbidities as well...
3.
Qiao L, Welch C, Hernan R, Wynn J, Krishnan U, Zalieckas J, et al.
Am J Hum Genet
. 2024 Sep;
111(11):2362-2381.
PMID: 39332409
Congenital diaphragmatic hernia (CDH) is a severe congenital anomaly often accompanied by other structural anomalies and/or neurobehavioral manifestations. Rare de novo protein-coding variants and copy-number variations contribute to CDH in...
4.
Xicoy B, Pomares H, Morgades M, Germing U, Arnan M, Tormo M, et al.
Front Oncol
. 2024 Jul;
14:1385987.
PMID: 39011475
Introduction: Chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or mutation (MDS-RS/) differ in many clinical features, but share others, such as anemia. RS and mutation...
5.
Kasprzak A, Andresen J, Nachtkamp K, Kundgen A, Schulz F, Strupp C, et al.
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398198
Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying therapies are...
6.
Schulz F, Jager P, Tischer J, Fraccaroli A, Bug G, Hausmann A, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339283
Up to 50% of patients with high-risk myeloid malignancies die of relapse after allogeneic stem cell transplantation. Current sequential conditioning regimens like the FLAMSA protocol combine intensive induction therapy with...
7.
Schulz F, Nachtkamp K, Oster H, Mittelman M, Gattermann N, Schweier S, et al.
Int J Lab Hematol
. 2024 Jan;
46(3):510-514.
PMID: 38284270
Introduction: A previously published web-based App using Gradient-boosted models (GBMs) of eight laboratory parameters was established by Oster et al. to facilitate diagnosis or exclusion of myelodysplastic syndromes (MDS) in...
8.
Schulz F, Hauch U, Ketzler-Henkel S, von der Heyde E, Koenigsmann M, Lauseker M, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892707
Myelodysplastic syndromes and myeloproliferative neoplasms both represent hematologic diseases associated with bone marrow failure often resulting in anemia. For those patients, transfusion of red blood cell (RBC) units is essential...
9.
Schulz F, Nachtkamp K, Kasprzak A, Gattermann N, Haas R, Germing U
Expert Rev Hematol
. 2021 Jun;
14(6):509-516.
PMID: 34161752
Introduction: Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell diseases characterized by cell dysplasia, ineffective hematopoiesis and risk of transformation to acute myeloid leukemia (AML). The median...
10.
Schulz F, Jenetzky E, Zwink N, Bendixen C, Kipfmueller F, Rafat N, et al.
BMC Pediatr
. 2021 Jun;
21(1):278.
PMID: 34126946
Background: Evidence for periconceptional or prenatal environmental risk factors for the development of congenital diaphragmatic hernia (CDH) is still scarce. Here, in a case-control study we investigated potential environmental risk...